Caroline Gaudy-Marqueste

4PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 26, 2026
Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.

|Aug 14, 2026
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance.

|Nov 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma.

Nausicaa Malissen, Nicolas Macagno, Samuel Granjeaud

Pageof 1

Frequent Collaborators

2 joint publications

Nicolas Macagno

2 joint publications

Robert Ballotti

1 joint publications

Nausicaa Malissen

1 joint publications

Samuel Granjeaud